Arti-Cell® Forte and RenuTend® market recall of select product batches
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Arti-Cell Forte
|
| Active substance |
Equine allogeneic mesenchymal stem cells
|
| DHPC type |
Quality defect
|
| Veterinary ATC codes |
QM09AX90
|
| Species |
Horses
|